A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

NCT07496567 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

960

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration
Age-Related Macular Degeneration
Choroidal Neovascularization
Wet Macular Degeneration

Interventions

DRUG: Tiespectus
DRUG: Aflibercept

Sponsor

EyeBiotech Ltd.